CA Patent

CA2953653C — Method for producing synthetic pentapeptide

Assigned to Maruishi Pharmaceutical Co Ltd · Expires 2021-02-16 · 5y expired

What this patent protects

Provided are: a method for industrially advantageously producing a high-purity pentapeptide; and a production intermediate thereof. A compound represented by formula (1) or a salt thereof. (In the formula, R1 represents an alkyl group or an aralkyl group.)

USPTO Abstract

Provided are: a method for industrially advantageously producing a high-purity pentapeptide; and a production intermediate thereof. A compound represented by formula (1) or a salt thereof. (In the formula, R1 represents an alkyl group or an aralkyl group.)

Drugs covered by this patent

Patent Metadata

Patent number
CA2953653C
Jurisdiction
CA
Classification
—
Expires
2021-02-16
Drug substance claim
No
Drug product claim
No
Assignee
Maruishi Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.